Prone Positioning Not Relevant to Survival Rate in Patients with ARDS
|
By HospiMedica International staff writers Posted on 30 Nov 2009 |
Prone positioning during mechanical ventilation may not improve survival duration in patients with acute respiratory distress syndrome (ARDS), according to a new study.
Researchers at the Ospedale Maggiore Policlinico di Milano (Italy) conducted the multicenter randomized Prone-Supine II trial to evaluate possible outcome benefits of prone positioning in patients with ARDS and moderate or severe hypoxemia. A total of 342 adults with ARDS receiving mechanical ventilation at 23 centers in Italy, and two in Spain, were enrolled in the study, and were prospectively stratified into subgroups with moderate and severe hypoxemia. The participants were randomly selected to supine positioning (174 patients) or prone positioning for 20 hours per day (168 patients) during ventilation. The main endpoint of the study was 28-day all-cause mortality, and secondary endpoints were 6-month mortality and mortality at intensive care unit discharge, organ dysfunction, and complication rate associated with prone positioning.
The researchers found that for the overall entire study population evaluated between February 2004 and June 2008, prone and supine positioning were associated with similar mortality rates at 28 days and six months; however, the prone group had a significantly higher complication rate. For patients with moderate hypoxemia, outcomes were also similar in the prone and supine groups at 28 days and at 6 months. For patients with severe hypoxemia, 28-day mortality rate was 37.8% in the prone group and 46.1% in the supine group, and six-month mortality rate was 52.7% and 63.2%, respectively. Positioning was not associated with any apparent differences in median sequential organ failure assessment (SOFA) scores, ventilator-free days, or intensive care unit length of stay. The study was published in the November 11, 2009, issue of the Journal of the American Medical Association (JAMA).
"Do the findings of this trial, together with those of previous studies, represent the end of the prone position technique?” inquired lead author Paolo Taccone, M.D., and colleagues of the department of anesthesia. "Undoubtedly, the data of the present trial together with previous results clearly indicate that prolonged prone positioning, in the unselected ARDS population, is not indicated as a treatment. However, its potential role in patients with the most severe hypoxemia, for whom the possible benefit could outweigh the risk of complications, must be further investigated.”
Related Links:
Ospedale Maggiore Policlinico di Milano
Researchers at the Ospedale Maggiore Policlinico di Milano (Italy) conducted the multicenter randomized Prone-Supine II trial to evaluate possible outcome benefits of prone positioning in patients with ARDS and moderate or severe hypoxemia. A total of 342 adults with ARDS receiving mechanical ventilation at 23 centers in Italy, and two in Spain, were enrolled in the study, and were prospectively stratified into subgroups with moderate and severe hypoxemia. The participants were randomly selected to supine positioning (174 patients) or prone positioning for 20 hours per day (168 patients) during ventilation. The main endpoint of the study was 28-day all-cause mortality, and secondary endpoints were 6-month mortality and mortality at intensive care unit discharge, organ dysfunction, and complication rate associated with prone positioning.
The researchers found that for the overall entire study population evaluated between February 2004 and June 2008, prone and supine positioning were associated with similar mortality rates at 28 days and six months; however, the prone group had a significantly higher complication rate. For patients with moderate hypoxemia, outcomes were also similar in the prone and supine groups at 28 days and at 6 months. For patients with severe hypoxemia, 28-day mortality rate was 37.8% in the prone group and 46.1% in the supine group, and six-month mortality rate was 52.7% and 63.2%, respectively. Positioning was not associated with any apparent differences in median sequential organ failure assessment (SOFA) scores, ventilator-free days, or intensive care unit length of stay. The study was published in the November 11, 2009, issue of the Journal of the American Medical Association (JAMA).
"Do the findings of this trial, together with those of previous studies, represent the end of the prone position technique?” inquired lead author Paolo Taccone, M.D., and colleagues of the department of anesthesia. "Undoubtedly, the data of the present trial together with previous results clearly indicate that prolonged prone positioning, in the unselected ARDS population, is not indicated as a treatment. However, its potential role in patients with the most severe hypoxemia, for whom the possible benefit could outweigh the risk of complications, must be further investigated.”
Related Links:
Ospedale Maggiore Policlinico di Milano
Latest Critical Care News
- Magnetic Control System Enables Precise Navigation of Miniature Medical Devices
- Noninvasive Skull Sensor Detects Early Deterioration in Acute Brain Injury
- Bacteria-Resistant Urinary Catheter Coating Reduces Infections and Antibiotic Use
- Sensor-Integrated Airway Stent Enables Continuous Remote Monitoring
- Graphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells
- Flexible Plastic Film Uses Nanostructures to Destroy Viruses
- Finger Cuff Algorithm Enables Noninvasive Screening for Aortic Stenosis
- Vibration-Based Tools Aim to Improve Newborn Screening for Heart Defects
- Dried Platelet Biologic Reduces Hemorrhage After Traumatic Brain Injury
- Minimally Invasive Probe Measures Key Metabolic Markers Simultaneously
- AI Expands Across Heart Failure Care Continuum to Improve Management
- Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
- Microneedle Sensor Enables Continuous Monitoring of Drug Clearance
- 3D Brain Imaging Marker Predicts Surgical Outcomes in Dementia-Causing Hydrocephalus
- Printed Artificial Neurons Stimulate Natural Brain Circuits
- Review Advances Precision Care Pathway for Meningioma Management
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreSurgical Techniques
view channel
New AI Tool Predicts Complications Before Lung Cancer Surgery
Lung cancer remains a leading cause of cancer mortality, and many surgical candidates present with complex comorbidities. Postoperative complications are common, making accurate and individualized risk... Read more
First Automated Insulin Delivery System Cleared for Type 1 Diabetes in Pregnancy
Managing glycemia during pregnancy complicated by type 1 diabetes requires tight targets and sustained time in a pregnancy-specific glucose range. Clinicians and patients often rely on automated insulin... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channelBusiness
view channel
Johnson & Johnson Launches AI-Driven Cardiac Mapping System
Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more







